March 23, 2021
Here is the link.
Olympic Champion and author Kristi Yamaguchi joins You & Me to talk about supporting her daughter on the ice, her experience on Dancing with the Stars and the possibility for book number 4! Pick up a copy of 'Cara's Kindness' to help teach your children to pay it forward.
March 23, 2021
Here is the link.
As part of the Olympic edition of our series “Where Are They Now?”, Natalie Morales spotlights figure skater Kristi Yamaguchi, who won gold in 1992, and her decision not to participate in the 1994 Winter Games. “The pressure would just be immense,” Yamaguchi says.
March 23, 2021
Here is the link.
Olympic figure skating champion Kristi Yamaguchi chats with Erika Choung about her journey leading up to the Olympics, her charitable work, as well as her new book "Dream Big, Little Pig." This event took place on August 23, 2011 in Google's Mountain View, CA headquarters, as part of the @Google Talks series. Kristi Yamaguchi is an American figure skater and 1992 Olympic Champion in ladies' singles. She is also a World Figure Skating Champion in 1991-1992 and National Champion in 1992. In December of 2005, she was inducted into the U.S. Olympic Hall of Fame and in 2008, Kristi also added winner of Dancing with the Stars to her accolades. Kristi has recently penned the bestseller "Dream Big, Little Pig" and has established the Always Dream Foundation for children.
Here is the link.
Jesse Draper chats with Kristi Yamaguchi.
March 23, 2021
Here is the link.
Kristi Yamaguchi’s work ethic and drive from an early age propelled her to win the Olympic gold medal in figure skating for the U.S.A. in 1992. She went on to become a professional ice skater, author and now, philanthropist. She reached into the lessons of her childhood to create the Always Dream Foundation.
March 23, 2021
Here is the link.
Kristi Yamaguchi, legendary figure skater and the founder of the Always Dream Foundation, talks to Ali about the fear among the Asian community. While her grandfather was serving in the U.S. Army, Kristi’s mother was born in a WWII internment camp. She says she now tells her parents to “be aware of what's going on around you whenever you're out and about” and says, “it's not just going to take the Asian American community, but...everyone as a whole coming together.”» Subscribe to MSNBC: http://on.msnbc.com/SubscribeTomsnbc
Kristine Tsuya Yamaguchi (born July 12, 1971) is an American former figure skater. In ladies' singles, Yamaguchi is the 1992 Olympic champion, a two-time World champion (1991 and 1992), and the 1992 U.S. champion. As a pairs skater with Rudy Galindo, she is the 1988 World Junior champion and a two-time national champion (1989 and 1990). In December 2005, she was inducted into the U.S. Olympic Hall of Fame. In 2008, Yamaguchi became the celebrity champion in the sixth season of Dancing with the Stars.
Here is the link.
Asian-Americans are demanding action on what they're calling a pandemic of racism. Six women of Asian descent were among eight people shot dead at massage parlours near Atlanta. Asian-Americans have reported increased attacks since the start of the pandemic. But historians point to a long history of sentiment against Asians in American society. So can anything be done to stop the hate?
March 23, 2021
Introduction
It is a busy day since my positions have over $500 dollars loss on my IRA account, and also I decided to make some purchases as well.
My gains
March 22, 2021
Here is the link.
HTTP was designed to be half-duplex which means it allows transmission of data in just one direction at a time. A Walkie-talkie is an example of a half duplex device because only one person can speak at a time. Developers have created some workarounds or hacks to overcome this HTTP shortcoming. Some of these workarounds are polling, long polling, and streaming.
March 21, 2021
Here is the link.
This week, we're live from FBMaryville's leadership luncheon. Every month, Tom sits down with leaders from around the community to talk about challenges facing them in their businesses. At September's meeting, the CEO of The Boeing Company, Dennis Muilenburg, joined the conversation to discuss the integration of faith and work. He brings some great insights into navigating negotiations and surprises while maintaining integrity.
If you enjoy today's episode, head over to iTunes and leave us a rating & review. It helps expand our influence and allows us to keep bringing you great content from week-to-week.
March 21, 2021
Here is the link.
Dennis A. Muilenburg, Chairman, President, and Chief Executive Officer, The Boeing Company, speaks with Economic Club president David M. Rubenstein on Wednesday May 9, 2018
The chatting history for this WeChat group "投资小群" is shown below.
————— 2021-03-21 —————
陈建敏 21:53
大家在群里轻松一点。发生一点冲突很正常。
陈建敏 21:55
周日晚上推荐大家看一看这个看投资股市发财几十亿价值David 采访波音前CEO, net worth 1 billion. 了解一下2018之前波音。
陈建敏 21:56
陈建敏 21:57
[weixinfile: https://youtu.be/pGMNbF5A_40]
陈建敏 22:03
大家没事看看这个71岁38亿身家老头采访不同名人。
陈建敏 22:03
March 21, 2021
Here is the link.
Aug.08 -- Boeing CEO Dennis Muilenburg talks to David Rubenstein about how he went from growing up a farm in Iowa to running Boeing, and he describes the future of air travel, including two-hour trips between any cities in the world. The interview was taped in Washington on May 9.
March 21, 2021
My notes:
Dennis Muilenburg Net Worth:
Dennis Muilenburg net worth and salary: Dennis Muilenburg is an American businessman who has a net worth of $100 million. Dennis Muilenburg was born in Orange City, Iowa in 1964. He formerly served as the president, chairman, and chief executive officer of The Boeing Company. Muilenburg took over the role of CEO in July 2015. He was fired on December 23, 2019 in wake of Boeing's 737 Max crisis. He had already been stripped of the chairman title and all but his base salary of compensation.
He graduated from Iowa State University and the University of Washington. Dennis Muilenburg made just over $15 million in salary in 2016. He began working at Boeing in 1985 and has held various management and engineering positions with the company including vice president of the Boeing Combat Systems division and president and chief executive officer of Boeing Defense, Space & Security. After becoming CEO in 2015 he would become chairman and then chairman of the board of directors in 2016.
As of January 2019, Dennis Muilenburg owned 130,000 shares of Boeing which have a pre-tax market value of $40 million. That made him one of the four largest individual shareholders of the company. He earned $23.4 million in total compensation for 2018. For 2019 he likely earned just his base salary which amounts to around $3 million. When he earned $23.4 million in 2014, roughly $20.4 million was a mix of bonus and stock options.
Upon being fired from Boeing, it was revealed that Dennis would be allowed to walk away with $18.5 million worth of exercised stock options and $62 million worth of pay and pension benefits for a total exit package north of $80 million. By comparison, Boeing set aside $50 million to compensate family members of 737 crash victims.
March 21, 2021
Here is the link.
Boeing CEO Dennis Muilenburg speaks with CNBC about the fallout from the 737 Max controversy.
I like to learn from Boeing CEO and his presentation in the interview. I like to start to look into Boeing as a company, and how to make profit in the long term.
I did have a good friend in wechat group, and she invested over $40,000 US dollars starting from July to Oct. 2020. I like to push myself to learn how to do good research on Boeing as well.
March 21, 2021
Introduction
I have to train myself to learn and read better on Yahoo -> Finance -> Financials. I like to go over those statements and then compare those data shown in the article.
My study
30 minutes drill
I like to spend at least 30 minutes to go over Financials of RIG stock by myself.
Let's face it, the thesis that ultra-deepwater offshore drilling would be the future of the oil industry has proven to be completely false. And companies like Transocean, which committed billions of dollars to the effort, are paying the price.
Revenue has stagnated as management has just tried to keep rigs busy, and losses have mounted over the last three years with no end in sight.
The trends going forward don't look good either. Oil prices are remaining stubbornly low and offshore drilling rig activity has plummeted in 2020. And Transocean has $8.3 billion of debt hanging over the company.
To be fair, Transocean does have $1.83 billion of cash on the balance sheet, but it also has a lot of obligations this year. $652 million in debt due in 2021 and a total of $1.1 billion will be needed to pay back debt and pay interest charges. On top of that, the company has $1.3 billion in newbuild obligations due in 2021. That cash will dry up quickly if the offshore drilling markets don't improve quickly.
The oil markets are in trouble amid the transition to electric vehicles, and that will continue to put pressure on oil prices. That ends up hurting companies like Transocean, which may be in bankruptcy court before an oil recovery ever comes.
First I like to look into debt, Financial -> Balance sheets
8.3 billion of debt hanging over the company.
March 21, 2021
Here is the link.
Cystic fibrosis NCLEX nursing review: Cystic fibrosis is a genetic disorder that causes the exocrine glands to work incorrectly. This can lead to major complications that affect the respiratory, digestive (pancreas, liver, intestines), integumentary, and reproductive systems along with the sinuses. What are exocrine glands? These are glands that produce and transfer it’s secretions (ex: mucous, tears, sweat, digestive enzymes) via DUCTS to it’s intended area of the body rather than directly into the bloodstream like the endocrine glands. In cystic fibrosis, there is a gene that is mutated that prevents the exocrine gland from working properly. It is called the CFTR gene! The CFTR gene, which stands for cystic fibrosis transmembrane regulator, is a protein that controls the channels of sodium and chloride. Hence the sodium and water transport in and out of the cell, and these channels are within the membrane of the cells that makes our sweat, mucous, tears, and digestive enzymes. However, in CF these channels don’t work properly. Therefore, normally these channels would properly regulated sodium and water transport in and out of the cells, which helps control the flow of water within these structures among other things. But this is not what happens in a person with cystic fibrosis. The mucous is thick and sticky rather than thin and slippery. This mucous will block the airways in the lower respiratory system and block the pancreatic duct from delivering pancreatic enzymes. In addition, the sweat glands produce excessive amounts of salt. CF tends to affect Caucasians and males more. The current median life expectancy of a person with cystic fibrosis is 37 years of age (source: NIH.gov). It is currently diagnosed with a sweat test where pilocaprine and electric current is delivered to the skin to make it sweat. The amount of salt in the sweat is measured. Results 60 mmol/L or more is considered positive for CF. Nursing interventions to cystic fibrosis include: chest physiotherapy (chest PT), monitor for complications, educating about PEP devices, preventing infection, administering medications and more (see the video for a detailed review of the nursing interventions)
囊性纤维化是由位于第7对染色体CF基因突变引起的常染色体隐性遗传病。病人是纯合子，其双亲是杂合子。病人的同胞中半数可带有隐性基因，而1/4可得病。一般带有隐性基因的杂合子占新生儿的2%～5%，2000～2500个新生儿中有一个患此病。囊性纤维化外分泌腺机能障碍的发病机理尚不清楚。研究显示，患者的上皮细胞氯离子通道调节有缺陷，呼吸道黏膜上皮的水、电解质跨膜转运有障碍，黏液腺分泌物中酸性糖蛋白含量增加，改变了黏液流变学的特性，可能为分泌物变黏稠的原因。
March 21, 2021
I bought 100 shares of TBIO at price around $17/ share, which was plummeted from above $50/ share, and the biotech is to cure cystic fibrosis. I finally found the time to watch a video related to this disease, the biotech is related to mRNA.
Here is the link.
Rebecca Schroeder has a background in chemistry, and a child with a rare genetic disease called Cystic Fibrosis. In this video, she describes the last miraculous decade of medical research and advocacy, which has transformed the lives of many living with cystic fibrosis. Progress is FANTASTIC, but we won't stop until it's done...and 100% of cystic fibrosis patients have a cure. Rebecca grew up in small-town Kooskia, ID and earned degrees in Chemistry and Spanish at the University of Idaho in Moscow. Rebecca's life was turned upside down in 2007, when her newborn son was diagnosed with a life-shortening, rare, genetic disease called cystic fibrosis. Her background in chemistry facilitated a fascinating deep dive into the world of pharmaceutical research and drug development, which recently yielded a massive breakthrough in treatment of CF. Rebecca continues to be a passionate advocate for those living with pre-existing conditions in her volunteer work with the Cystic Fibrosis Foundation. When Rebecca isn’t in Coeur d' Alene with her husband Brock and son Brady, she can be found organizing citizen volunteers in every corner of the state as Executive Director of the non-partisan political organization Reclaim Idaho. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
March 21, 2021
Here is the link.
Should I Invest in Boeing in late-2020 and 2021? We take a look at the ultra-beaten-down Boeing stock as a potential opportunity, after it's made some good gains in the last few weeks. Boeing's not only made up of commercial aircraft production, but has various other business segments, so we take a look at those and how they've been doing during these rough times, alongside the more well-known commercial aircraft segment. Looking forward to hearing your feedback in the comments section!
4180 737 MAX orders back in 2019 - 100 million a plane -> 40 billion dollars
March 21, 2021
Here is the link.
Are you new to the stock market? Would like some help getting started with your new dividend portfolio? You now have the chance to speak to me live through a cell phone session. For $25 you can schedule a half hour mentoring session in which I directly help you with your investments! This gives you the opportunity to ask me dozens of questions you wouldn't have had the opportunity in a regular video! A larger return in a portfolio makes an incredibly MASSIVE difference in the long term. (Not Financial Advice)
March 21, 2021
Introduction
It is my Sunday. I like to spend a few hours to work on BA stock equity research. I like to go over Yahoo -> Finance -> Conversation. I like to get updated with other investors.
Yahoo -> Finance -> Conversation
March 21, 2021
Here is the link.
I bought some biotech to apply gene therapy to treat some disease. The stock name is .
March 21, 2021
Here is the link.
Marcy Darnovsky, PhD, is Executive Director at the Center for Genetics and Society, a California-based public interest organization that works for a world in which human genetic and assisted reproductive technologies benefit the common good. Marcy’s talk covers exactly that. She has recently focused on the prospect that heritable genome editing could undermine our chances for an inclusive future. Her articles on this have appeared in publications including The New York Times, Los Angeles Times, National Geographic, and others. Dr. Darnovsky addresses the pros and cons surrounding programs such as CRISPR, focusing on gene editing. Marcy Darnovsky, PhD, is Executive Director at the Center for Genetics and Society, a Berkeley, California-based public interest organization that works for a world in which human genetic and assisted reproductive technologies benefit the common good. Darnovsky speaks and writes widely about the social justice and human rights implications of human biotechnologies. Recently she has focused on the prospect that heritable genome editing could undermine our chances for a fair and inclusive future. Her articles on this topic have appeared in publications including The New York Times, Financial Times, Los Angeles Times, The Guardian, The Hill, National Geographic, and Nature. She is co-editor, with Osagie K. Obasogie, of Beyond Bioethics: Toward a New Biopolitics (University of California Press, 2018). She has been interviewed by hundreds of television, radio, print, and online outlets. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
March 21, 2021
Here is the article.
Last on Needham’s value list is Graybug, a biopharmaceutical firm conducting clinical-stage research on medications to treat chronic diseases of the retina and optic nerve. The company focuses on long-term treatments, with drugs to be administered no more than twice per year – and provide relief from vision loss due to age-related macular degeneration and diabetic macular edema.
Graybug’s IPO in September was notably successful; the company started trading at $16 per share, above the $15 originally planned, and sold almost 1 million more shares than first announced.
Biotech firms are famously mercurial as stock investments. They tend to run deep losses for long periods, as medical research is both expensive and impossible to short cut. The rewards, however, are real, as one popular drug, or a treatment that is perceived as essential, can bring in tremendous profits once it goes on the market. That’s the value Needham sees here.
Starting coverage on this stock for Needham is analyst Serge Belanger, who says of GRAY, “Anti-VEGF therapies generate ~$12B in WW sales as the standard of care for retinal diseases despite 40%-50% of patients experiencing inadequate responses and a treatment burden that impacts patient compliance. We believe [the company's] GB-102 can disrupt the anti-VEGF market with a differentiated mechanism of action and longer-dosing intervals. Upcoming ph 2b trial data in 1H21 represent the most near-term value-driving catalyst.”
In line with his outlook, Belanger rates the stock a Buy. His $30 price target represents an impressive 96% upside potential for the year ahead. (To watch Belanger’s track record, click here)
Wall Street agrees that GRAY is a buying proposition. The stock has 6 recent reviews, and all are Buys, making the Strong Buy consensus rating unanimous. Shares are selling for $15.32, and the $32.50 average price target implies an upside of 115%. (See GRAY stock analysis on TipRanks)
GRAY stock
Here is the link.
If you were asked, what was the one sense that you couldn't live without, most of you would have immediately thought of your sight. That is because our vision plays an integral role in how we perceive the world around us. Without research into the prevention of vision loss from retinal degenerations, it is guaranteed that 1 in 7 people will lose the sense of sight.
Research led by Dr Riccardo Natoli and his research team focuses on what causes the retina, the part of the eye responsible for converting light to an electrical signal that our brain can understand, to degenerate with age. This degeneration can lead to irreparable loss of retinal cells causing permanent blindness.
Our lab studies a number of retinal diseases such as Retinopathy of Prematurity, Retinitis Pigmentosa and Diabetic Retinopathy, but focuses on finding novel diagnostics and treatment options for Age-Related Macular Degeneration (AMD). The most common cause of blindness in Australia is AMD, costing the Australian economy ~5 billion dollars annually (Deloitte – Eyes on the Future, 2011). Current projections indicate that by 2030, 1.7 million people in Australia will have vision loss resulting from AMD.
Our most recent work has been involved in elucidating the role of miRNA in the degenerating retina, their role in modulating inflammation and there potential use as both therapeutics and diagnostics for the currently untreatable dry AMD.
March 21, 2021
Here is the link.
Energy stocks had a rough year in 2020. Oil prices went negative for a brief moment and demand is down because people are traveling less during the pandemic.
To make matters worse, the transition from fossil fuels to renewable energy continues in the electricity sector, leaving coal in the dust. As the energy industry has dealt with a pandemic and macro trends, there are a few companies that may end up going bankrupt relatively soon. Peabody Energy (NYSE:BTU), Transocean (NYSE:RIG), and Occidental Petroleum (NYSE:OXY) could be some of the biggest names to fall.
It hasn't been long since Peabody Energy was in bankruptcy court, so the company is familiar with the process. And it may be headed back into bankruptcy unless we see some kind of turnaround in coal demand, which seems unlikely at this point.
You can see below that Peabody's revenue has dropped like a rock, losses are mounting, and free cash flow is negative. No matter how you look at it, the company's operations are in shambles.
The worst news is that coal consumption from U.S. power plants continues on a long decline. And there's no end in sight, with the number of operational plants in decline and renewable energy now costing less for new power plants.
Peabody Energy does have some bright spots, including metallurgical coal and exports, but they're not nearly enough to make up for the loss in U.S. thermal coal demand.
Bottom line, there isn't a bright future for coal or Peabody Energy, and that's why the company may eventually end up in bankruptcy -- again.
Let's face it, the thesis that ultra-deepwater offshore drilling would be the future of the oil industry has proven to be completely false. And companies like Transocean, which committed billions of dollars to the effort, are paying the price.
Revenue has stagnated as management has just tried to keep rigs busy, and losses have mounted over the last three years with no end in sight.
The trends going forward don't look good either. Oil prices are remaining stubbornly low and offshore drilling rig activity has plummeted in 2020. And Transocean has $8.3 billion of debt hanging over the company.
To be fair, Transocean does have $1.83 billion of cash on the balance sheet, but it also has a lot of obligations this year. $652 million in debt due in 2021 and a total of $1.1 billion will be needed to pay back debt and pay interest charges. On top of that, the company has $1.3 billion in newbuild obligations due in 2021. That cash will dry up quickly if the offshore drilling markets don't improve quickly.
The oil markets are in trouble amid the transition to electric vehicles, and that will continue to put pressure on oil prices. That ends up hurting companies like Transocean, which may be in bankruptcy court before an oil recovery ever comes.
March 20, 2021
Here is the link.
Shares of energy services provider Transocean (NYSE:RIG) rose by a huge 25% in December according to data from S&P Global Market Intelligence. That's a massive increase, but it comes off a very low base, given that even after the December advance the stock was off by 66% in 2020. Both of those numbers come right back to oil.
Transocean's customers are energy exploration and production (E&P) companies. The relationship is fairly straightforward. When oil prices are high, E&Ps tend to invest heavily to find and produce new oil. When oil prices are low, E&Ps pull back on such capital investments. The impact on Transocean's business should be obvious: When its customers are spending aggressively it does well; when spending is low it doesn't. With oil plunging in 2020 thanks to the economic shutdowns used to slow the spread of the coronavirus, the energy industry pulled back hard and Transocean's stock fell as investors anticipated a period of poor operating performance.
March 20, 2021
Here is the link.
I like to take one hour break and learn more about this Asian hate. I like to learn more about this and look into more carefully.
